BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19628038)

  • 1. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
    Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
    Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
    J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
    Cavalieri E; Rogan E
    Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.
    Zahid M; Saeed M; Lu F; Gaikwad N; Rogan E; Cavalieri E
    Free Radic Biol Med; 2007 Dec; 43(11):1534-40. PubMed ID: 17964424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol.
    Zahid M; Gaikwad NW; Ali MF; Lu F; Saeed M; Yang L; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2008 Jul; 45(2):136-45. PubMed ID: 18423413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells.
    Lu F; Zahid M; Wang C; Saeed M; Cavalieri EL; Rogan EG
    Cancer Prev Res (Phila); 2008 Jul; 1(2):135-45. PubMed ID: 19138946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells.
    Yang L; Zahid M; Liao Y; Rogan EG; Cavalieri EL; Davidson NE; Yager JD; Visvanathan K; Groopman JD; Kensler TW
    Carcinogenesis; 2013 Nov; 34(11):2587-92. PubMed ID: 23843041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
    Yager JD
    Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.
    Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E
    Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
    Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
    Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.
    Markushin Y; Zhong W; Cavalieri EL; Rogan EG; Small GJ; Yeung ES; Jankowiak R
    Chem Res Toxicol; 2003 Sep; 16(9):1107-17. PubMed ID: 12971798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of depurinating estrogen-DNA adduct formation by natural compounds.
    Zahid M; Gaikwad NW; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 2007 Dec; 20(12):1947-53. PubMed ID: 18039013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
    Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells.
    Zahid M; Saeed M; Beseler C; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2011 Jan; 50(1):78-85. PubMed ID: 20934508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.
    Zahid M; Saeed M; Ali MF; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2010 Aug; 49(3):392-400. PubMed ID: 20472053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
    Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
    Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
    Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
    Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.